Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezekowitz

Showing results (671-680 of 842) with videos related to

Pageof 85
Sort By:
Cell|October 22, 2005
Eater, a transmembrane protein mediating phagocytosis of bacterial pathogens in DrosophilaChristine Kocks, Ju Hyun Cho, Nadine Nehme, et al.
The American Journal of Cardiology|August 14, 2003
Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])Steven N Singh, Bramah N Singh, Domenic J Reda, et al.
Journal of Thrombosis and Thrombolysis|July 28, 2018
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryLarry R Jackson, Sunghee Kim, Peter Shrader, et al.
European Heart Journal|May 2, 2017
Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)Peter S Pang, Javed Butler, Sean P Collins, et al.
Circulation. Heart Failure|October 5, 2014
Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HFPriyesh A Patel, Gretchen Heizer, Christopher M O'Connor, et al.
European Journal of Heart Failure|June 30, 2021
Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the VICTORIA trialPiotr Ponikowski, Wendimagegn Alemayehu, Ali Oto, et al.
JACC. Heart Failure|February 5, 2015
Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure)G Michael Felker, Javed Butler, Sean P Collins, et al.
The New England Journal of Medicine|August 26, 2023
Ferric Carboxymaltose in Heart Failure with Iron DeficiencyRobert J Mentz, Jyotsna Garg, Frank W Rockhold, et al.
International Journal of Cardiology|May 4, 2020
Cardiovascular disease burden in adult patients with cancer: An 11-year nationwide population-based cohort studyJong-Chan Youn, Woo-Baek Chung, Justin A Ezekowitz, et al.
Journal of the American College of Cardiology|March 26, 2016
Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF StudyJohn R Teerlink, G Michael Felker, John J V McMurray, et al.
Pageof 85

Showing results (671-680 of 842) with videos related to

Sort By:
Pageof 85
Cell|October 22, 2005
Eater, a transmembrane protein mediating phagocytosis of bacterial pathogens in DrosophilaChristine Kocks, Ju Hyun Cho, Nadine Nehme, et al.
The American Journal of Cardiology|August 14, 2003
Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T])Steven N Singh, Bramah N Singh, Domenic J Reda, et al.
Journal of Thrombosis and Thrombolysis|July 28, 2018
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryLarry R Jackson, Sunghee Kim, Peter Shrader, et al.
European Heart Journal|May 2, 2017
Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF)Peter S Pang, Javed Butler, Sean P Collins, et al.
Circulation. Heart Failure|October 5, 2014
Hypotension during hospitalization for acute heart failure is independently associated with 30-day mortality: findings from ASCEND-HFPriyesh A Patel, Gretchen Heizer, Christopher M O'Connor, et al.
European Journal of Heart Failure|June 30, 2021
Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the VICTORIA trialPiotr Ponikowski, Wendimagegn Alemayehu, Ali Oto, et al.
JACC. Heart Failure|February 5, 2015
Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure)G Michael Felker, Javed Butler, Sean P Collins, et al.
The New England Journal of Medicine|August 26, 2023
Ferric Carboxymaltose in Heart Failure with Iron DeficiencyRobert J Mentz, Jyotsna Garg, Frank W Rockhold, et al.
International Journal of Cardiology|May 4, 2020
Cardiovascular disease burden in adult patients with cancer: An 11-year nationwide population-based cohort studyJong-Chan Youn, Woo-Baek Chung, Justin A Ezekowitz, et al.
Journal of the American College of Cardiology|March 26, 2016
Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF StudyJohn R Teerlink, G Michael Felker, John J V McMurray, et al.
Pageof 85